← Evidence map

ArticleFrontiers in aging neuroscience2024

EBF1 is a potential biomarker for predicting progression from mild cognitive impairment to Alzheimer's disease: an

Yanxiu Ju et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39347016